R/R LBCLAxicabtagene Ciloleuceltisagenlecleucellisocabtagene maraleucelChimeric antigen receptor (CAR) T-cell therapies
…. Locke FL, et al. Impact of Vein-to-vein Time in Patients With R/R LBCL Treated with Axicabtagene Ciloleucel. Blood Adv. 2025 Jun 10;9(…